scholarly journals Estimating the Impact of Changes to Occupational Standards for Silica Exposure on Lung Cancer Mortality

Epidemiology ◽  
2018 ◽  
Vol 29 (5) ◽  
pp. 658-665 ◽  
Author(s):  
Alexander P. Keil ◽  
David B. Richardson ◽  
Daniel Westreich ◽  
Kyle Steenland
2021 ◽  
Vol 60 (2) ◽  
pp. 36-38
Author(s):  
B. А. Abdurakhmanov ◽  
Z. К. Avizovа

Lung cancer is still leading in the structure of cancer incidence and mortality worldwide. Delay in appropriate treatment increases the probability of death from this disease. Purpose: to study foreign scientific publications of recent years on the mortality from lung cancer due to delayed treatment. Results: The analysis of global literature for 2010-2020 shows that any delay in lung cancer treatment after establishing the diagnosis reduces the survival rates. Recent studies provide a qualitative assessment of the effect of delay in treatment on cancer mortality for prioritization and modeling. The indications for surgery, systemic treatment, and radiation therapy in seven types of cancer, including lung cancer, evidence a significant association between delay in treatment and increased mortality. The researchers believe that early diagnostics increase the treatment efficacy. Conclusion: Analyzing the barriers to timely treatment for lung cancer can help clarify and assess the impact of delayed treatment on survival. Policies designed to minimize delays in treatment can improve survival outcomes.


2013 ◽  
Vol 107 (5) ◽  
pp. 702-707 ◽  
Author(s):  
Juan P. de-Torres ◽  
Ciro Casanova ◽  
Jose M. Marín ◽  
Jorge Zagaceta ◽  
Ana B. Alcaide ◽  
...  

2019 ◽  
Vol 76 (Suppl 1) ◽  
pp. A24.2-A24
Author(s):  
Alex Keil ◽  
David Richardson ◽  
Daniel Westreich ◽  
Kyle Steenland

BackgroundRespiratory exposure to silica is associated with the risk of death due to malignant and non-malignant disease. 2.3 million U.S. workers are exposed to silica. Occupational exposure limits for silica are derived from a number of lines of evidence, including observational studies. Observational studies may be subject to healthy worker survivor bias, which could result in underestimates of silica’s impact on worker mortality and, in turn, bias risk estimates for occupational exposure limits.MethodsUsing data on 65 999 workers pooled across multiple industries, we estimate the impacts of several hypothetical occupational exposure limits on silica exposure on lung cancer and all-cause mortality. We use the parametric g-formula, which can account for healthy worker survivor bias.ResultsAssuming we could eliminate occupational exposure, we estimate that there would be 20.7 fewer deaths per 1000 workers in our pooled study by age 80 (95% confidence interval: 14.5, 26.8), including 3.91 fewer deaths due to lung cancer (95% CI: 1.53, 6.30). Less restrictive interventions demonstrated smaller, but still substantial risk reductions.ConclusionsOur results suggest that occupational exposure limits for silica can be further strengthened to reduce silica-associated mortality and illustrate how current risk analysis for occupational limits can be improved.


2016 ◽  
Vol 49 (5) ◽  
pp. e134-e140 ◽  
Author(s):  
Takeshi Nagayasu ◽  
Shuntaro Sato ◽  
Hiroshi Yamamoto ◽  
Naoya Yamasaki ◽  
Tomoshi Tsuchiya ◽  
...  

2014 ◽  
Vol 32 (5) ◽  
pp. 444-448 ◽  
Author(s):  
Samir Soneji ◽  
Hiram Beltrán-Sánchez ◽  
Harold C. Sox

Purpose Measuring the effect of cancer interventions must take into account rising cancer incidence now that people live longer because of declines in mortality from cardiovascular disease (CVD). Cancer mortality rates in the population do not accomplish this objective. We sought a measure that would reveal the effects of changing mortality rates from other diseases. Methods We obtained annual breast, colorectal, lung, and prostate cancer mortality rates from the Surveillance, Epidemiology, and End Results registries; we obtained noncancer mortality rates from national death certificates, 1975 to 2005. We used life-table methods to calculate the burden of cancer mortality as the average person-years of life lost (PYLL) as a result of cancer (cancer-specific PYLL) and quantify individual—and perhaps offsetting—contributions of the two factors that affect cancer-specific PYLL: mortality rates as a result of cancer and other-cause mortality. Results Falling cancer mortality rates reduced the burden of mortality from leading cancers, but increasing cancer incidence as a result of decreasing other-cause mortality rates partially offset this progress. Between 1985 and 1989 and between 2000 and 2004, the burden of lung cancer in males declined by 0.1 year of life lost. This decline reflects the sum of two effects: decreasing lung cancer mortality rates that reduced the average burden of lung cancer mortality by 0.33 years of life lost and declining other-cause mortality rates that raised it by 0.23 years. Other common cancers showed similar patterns. Conclusion By using a measure that accounts for increased cancer incidence as a result of improvements in CVD mortality, we find that prior assessments have underestimated the impact of cancer interventions.


Thorax ◽  
1999 ◽  
Vol 54 (1) ◽  
pp. 56-59 ◽  
Author(s):  
H. Checkoway ◽  
J. M Hughes ◽  
H. Weill ◽  
N. S Seixas ◽  
P. A Demers

Sign in / Sign up

Export Citation Format

Share Document